Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Statistics

Total Valuation

ASX:CU6 has a market cap or net worth of AUD 1.63 billion. The enterprise value is 1.52 billion.

Market Cap	1.63B
Enterprise Value	1.52B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:CU6 has 371.91 million shares outstanding. The number of shares has increased by 15.21% in one year.

Current Share Class	371.91M
Shares Outstanding	371.91M
Shares Change (YoY)	+15.21%
Shares Change (QoQ)	+11.53%
Owned by Insiders (%)	15.76%
Owned by Institutions (%)	22.08%
Float	274.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	151.16
PB Ratio	12.79
P/TBV Ratio	12.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.16
EV / Sales	140.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-32.29

Financial Position

The company has a current ratio of 14.55

Current Ratio	14.55
Quick Ratio	13.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.99% and return on invested capital (ROIC) is -39.07%.

Return on Equity (ROE)	-53.99%
Return on Assets (ROA)	-36.11%
Return on Invested Capital (ROIC)	-39.07%
Return on Capital Employed (ROCE)	-44.17%
Revenue Per Employee	215,536
Profits Per Employee	-974,066
Employee Count	50
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:CU6 has paid 236,444 in taxes.

Income Tax	236,444
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.48% in the last 52 weeks. The beta is 1.49, so ASX:CU6's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-24.48%
50-Day Moving Average	3.02
200-Day Moving Average	3.61
Relative Strength Index (RSI)	66.28
Average Volume (20 Days)	3,947,887

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CU6 had revenue of AUD 10.78 million and -48.70 million in losses. Loss per share was -0.16.

Revenue	10.78M
Gross Profit	10.78M
Operating Income	-56.39M
Pretax Income	-48.47M
Net Income	-48.70M
EBITDA	-56.21M
EBIT	-56.39M
Loss Per Share	-0.16

Balance Sheet

The company has 111.19 million in cash and n/a in debt, giving a net cash position of 111.19 million or 0.30 per share.

Cash & Cash Equivalents	111.19M
Total Debt	n/a
Net Cash	111.19M
Net Cash Per Share	0.30
Equity (Book Value)	127.35M
Book Value Per Share	0.40
Working Capital	127.10M

Cash Flow

In the last 12 months, operating cash flow was -46.84 million and capital expenditures -166,614, giving a free cash flow of -47.01 million.

Operating Cash Flow	-46.84M
Capital Expenditures	-166,614
Free Cash Flow	-47.01M
FCF Per Share	-0.13

Margins

Gross Margin	100.00%
Operating Margin	-523.30%
Pretax Margin	-449.73%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:CU6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.21%
Shareholder Yield	n/a
Earnings Yield	-2.99%
FCF Yield	-2.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:CU6 has an Altman Z-Score of 92.26 and a Piotroski F-Score of 2.

Altman Z-Score	92.26
Piotroski F-Score	2